List of AnaptysBio patents

List of AnaptysBio patents

List of LaserMotive patents

List of InfaCare Pharmaceutical patents

List of Toshiba America Electronic Components patents

Films directed by Phil Rosen

List of vertical SaaS and internet of things (iot) companies

Patents where

Current Assignee

Name

is

AnaptysBio

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11352427 Antibodies directed against T Cell immunoglobulin and mucin protein 3 (TIM-3)	Patent 11352427 was granted and assigned to AnaptysBio on June, 2022 by the United States Patent and Trademark Office.	AnaptysBio	AnaptysBio		United States Patent and Trademark Office	11352427	June 7, 2022
	‌ US Patent 10508149 Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3)	Patent 10508149 was granted and assigned to AnaptysBio on December, 2019 by the United States Patent and Trademark Office.	AnaptysBio	AnaptysBio		United States Patent and Trademark Office	10508149	December 17, 2019
	‌ US Patent 10059764 Antibodies directed against interleukin-33 (IL-33) and methods of making and using	Patent 10059764 was granted and assigned to AnaptysBio on August, 2018 by the United States Patent and Trademark Office.	AnaptysBio	AnaptysBio		United States Patent and Trademark Office	10059764	August 28, 2018
	‌ US Patent 9133269 Humanized antibodies directed against complement protein C5	Patent 9133269 was granted and assigned to AnaptysBio on September, 2015 by the United States Patent and Trademark Office.	AnaptysBio	AnaptysBio		United States Patent and Trademark Office	9133269	September 15, 2015
	‌ US Patent 9815897 Antibodies directed against programmed death-1 (PD-1)	Patent 9815897 was granted and assigned to AnaptysBio on November, 2017 by the United States Patent and Trademark Office.	AnaptysBio	AnaptysBio		United States Patent and Trademark Office	9815897	November 14, 2017
	‌ US Patent 8685897 Methods of generating libraries and uses thereof	Patent 8685897 was granted and assigned to AnaptysBio on April, 2014 by the United States Patent and Trademark Office.		AnaptysBio		United States Patent and Trademark Office	8685897	April 1, 2014
	‌ US Patent 9328166 Antibodies directed against IL-17	Patent 9328166 was granted and assigned to AnaptysBio on May, 2016 by the United States Patent and Trademark Office.		AnaptysBio		United States Patent and Trademark Office	9328166	May 3, 2016
	‌ US Patent 8926978 Antibodies directed against nerve growth factor (NGF)	Patent 8926978 was granted and assigned to AnaptysBio on January, 2015 by the United States Patent and Trademark Office.	AnaptysBio	AnaptysBio		United States Patent and Trademark Office	8926978	January 6, 2015
	‌ US Patent 9637556 Methods of generating libraries and uses thereof	Patent 9637556 was granted and assigned to AnaptysBio on May, 2017 by the United States Patent and Trademark Office.	AnaptysBio	AnaptysBio		United States Patent and Trademark Office	9637556	May 2, 2017
	‌ US Patent 9951126 Antibodies directed against nerve growth factor (NGF)	Patent 9951126 was granted and assigned to AnaptysBio on April, 2018 by the United States Patent and Trademark Office.	AnaptysBio	AnaptysBio		United States Patent and Trademark Office	9951126	April 24, 2018
	‌ US Patent 10738117 Antibodies directed against programmed death-1 (PD-1)	Patent 10738117 was granted and assigned to AnaptysBio on August, 2020 by the United States Patent and Trademark Office.	AnaptysBio	AnaptysBio		United States Patent and Trademark Office	10738117	August 11, 2020
	‌ US Patent 10836820 Method of treating inflammatory disorder with antibodies directed against interleukin-33 (IL-33)	Patent 10836820 was granted and assigned to AnaptysBio on November, 2020 by the United States Patent and Trademark Office.	AnaptysBio	AnaptysBio		United States Patent and Trademark Office	10836820	November 17, 2020
	‌ US Patent 9260533 Methods of generating libraries and uses thereof	Patent 9260533 was granted and assigned to AnaptysBio on February, 2016 by the United States Patent and Trademark Office.	AnaptysBio	AnaptysBio		United States Patent and Trademark Office	9260533	February 16, 2016
	‌ US Patent 10836824 Antibodies directed against lymphocyte activation gene 3 (LAG-3)	Patent 10836824 was granted and assigned to AnaptysBio on November, 2020 by the United States Patent and Trademark Office.	AnaptysBio	AnaptysBio		United States Patent and Trademark Office	10836824	November 17, 2020
	‌ US Patent 11130814 Method of treating pustular psoriasis with antibodies directed against interleukin 36 receptor (IL-36R)	Patent 11130814 was granted and assigned to AnaptysBio on September, 2021 by the United States Patent and Trademark Office.	AnaptysBio	AnaptysBio		United States Patent and Trademark Office	11130814	September 28, 2021
	‌ US Patent 8603950 Methods of generating libraries and uses thereof	Patent 8603950 was granted and assigned to AnaptysBio on December, 2013 by the United States Patent and Trademark Office.		AnaptysBio		United States Patent and Trademark Office	8603950	December 10, 2013
	‌ US Patent 10526410 Antibodies directed against interleukin 36 receptor (IL-36R)	Patent 10526410 was granted and assigned to AnaptysBio on January, 2020 by the United States Patent and Trademark Office.	AnaptysBio	AnaptysBio		United States Patent and Trademark Office	10526410	January 7, 2020
	‌ US Patent 11999783 Method of treating autoimmune disease with antibodies against IL-33	Patent 11999783 was granted and assigned to AnaptysBio on June, 2024 by the United States Patent and Trademark Office.	AnaptysBio	AnaptysBio		United States Patent and Trademark Office	11999783	June 4, 2024

18 results

0 selected

18 results

0 selected